Zelira Therapeutics Limited
ZLDAF
$0.2992
$0.041616.15%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | -0.70% | -0.20% | 92.80% | 0.47% |
| Total Depreciation and Amortization | -2.78% | -24.59% | 0.15% | -26.08% | -0.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.73% | 82.47% | -0.21% | -106.77% | -0.47% |
| Change in Net Operating Assets | -- | -- | 0.19% | -- | -- |
| Cash from Operations | 2.74% | -0.75% | -0.21% | -54.72% | 0.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.20% | -- | -- |
| Cash from Investing | -- | -- | 0.20% | -- | -- |
| Total Debt Issued | 0.00% | -7.18% | 0.00% | 35.85% | 0.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.75% | -5.61% | 0.20% | 37.07% | -0.46% |
| Foreign Exchange rate Adjustments | 4.26% | -487.50% | 0.00% | 80.95% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.78% | -206.87% | 0.23% | 746.79% | 0.38% |